Karyopharm Therap
KPTI----
Forecast & Rating4 analysts currently cover Karyopharm Therap, of which 3 give a positive rating. The average price target is $7.33, about 42045.6% upside from the current price of $0.02. Coverage is limited, so the data is for reference only. Data as of Nov 10, 2026; this does not constitute investment advice.
Nov 3, 2026Price forecast
$7.3342045.57%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy25.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateNov 9, 2026
Forecast met4.2%
Stock price$0.02
Avg. target$14.7
High target$21
Low target$6
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.